Your session is about to expire
← Back to Search
Low-level Laser Therapy
Erchonia HLS for Tinnitus
N/A
Waitlist Available
Research Sponsored by Erchonia Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 8 week
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if a special red light can help reduce the ringing in the ears for adults with tinnitus. The light might work by calming nerves or reducing inflammation.
Eligible Conditions
- Tinnitus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 8 week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 8 week
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Total Score on the Tinnitus Handicap Inventory (THI).
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Erchonia HLSExperimental Treatment1 Intervention
635 nanometers (nm) laser application
Find a Location
Who is running the clinical trial?
Erchonia CorporationLead Sponsor
44 Previous Clinical Trials
2,064 Total Patients Enrolled
2 Trials studying Tinnitus
41 Patients Enrolled for Tinnitus
Share this study with friends
Copy Link
Messenger